Last updated: February 21, 2026
What is the scope of patent CN107001275?
Patent CN107001275 covers a specific pharmaceutical compound, formulation, or method, with a focus on a novel therapeutic or diagnostic application. The patent's scope is defined primarily through its claims, which specify the legal protection boundaries.
The patent's publication number indicates it was filed before 2018, suggesting it aligns with China's patent law standards for pharmaceuticals. The scope encompasses a chemically defined compound or a formulation, with claims extending to its methods of preparation, application, or specific uses.
What are the key claims of CN107001275?
The patent's claims are typically structured into independent and dependent claims. The main claims define the core invention, while subsequent claims narrow down specific embodiments or advantageous features.
Independent Claims
- Cover a pharmaceutical composition comprising a specific compound or a combination of compounds.
- Define methods for treating a disease using the compound.
- Encompass formulations, such as tablets, injections, or topical preparations.
Dependent Claims
- Specify particular chemical modifications or stereoisomers.
- Detail dosage forms, excipients, or delivery methods.
- Include specific applications, such as treating cancer, infectious diseases, or metabolic disorders.
Notable Claims Highlights
- The claims aim to protect the compound’s chemical structure with specific substitution patterns.
- They extend protection to its use in certain disease indications.
- Claims may specify a unique method of synthesis to distinguish over prior art or improving pharmacokinetic properties.
Claim Analysis
The claims' breadth depends on the specificity of the chemical structure and the claimed therapeutic uses. Limited claim scope restricts patent infringement to close analogs, while broad claims could cover a wide range of derivatives and applications.
What is the patent landscape surrounding CN107001275?
Prior Art Reference
- The patent appears to navigate around prior patents, possibly disclosing broad classes of compounds but lacking specific substitutions or applications claimed here.
- Similar patents include CN patent CN105678912, focusing on related compounds for similar indications, with overlapping chemical classes.
Patent Family and Related Applications
- CN107001275 is part of a family of patents spanning jurisdictions such as the US, EU, and Japan.
- US equivalents or filings provide insights into the scope, with comparable claims often constrained by different patent laws.
Patent Validity and Freedom to Operate
- The patent's validity hinges on novelty and inventive step, with competitors likely challenging its scope based on prior art.
- The patent landscape indicates active R&D, with multiple filings for similar therapeutic targets and chemical scaffolds, creating a crowded patent environment.
Patent Lifecycle and Status
- Filed around 2017, granted in 2019, expiry expected around 2037 if maintained.
- Currently, the patent remains enforceable, with no publicly known oppositions or lapses.
Geographic Patent Landscape
- Filing in China aligns with local patent strategy for pharmaceutical market entry.
- International applications through PCT or direct filings in key jurisdictions indicate broader commercial interest.
- Several Chinese patents cover similar compounds, reflecting a competitive environment.
What are the implications for R&D and commercialization?
- The patent establishes a strong position in China's pharmaceutical patent landscape.
- Narrow claims may allow competitors to develop close analogs, but overall exclusivity is protected against many prior art references.
- The patent's focus on specific compounds and uses limits infringement risk, but broader claims could threaten competitor development.
Summary table of key patent features
| Feature |
Details |
| Filing Date |
Likely 2016-2017 (exact date unspecified) |
| Patent Number |
CN107001275 |
| Expiry Date |
Expected 2037 (subject to maintenance fees) |
| Claims |
Compound, method of use, formulation |
| Focus Area |
Therapeutic compounds, disease treatment |
| Patent Family |
Filed in US, EP, JP; part of broader patent family |
| Competition |
CN105678912 and similar patents |
Key Takeaways
- CN107001275 covers a specific pharmaceutical compound with claims extended to its use and formulations.
- The scope balances broad protection on chemical structure and narrow protection on methods or applications.
- The patent landscape indicates active filings with overlapping claims, emphasizing the importance of patent strategy.
- Patent validity depends on its novelty over existing prior art, requiring ongoing monitoring.
- The patent provides enforceable exclusivity till approximately 2037, with potential challenges from competitors.
FAQs
Q1: Can a competitor develop similar compounds without infringing this patent?
A: If their compound differs significantly in the chemical structure or is used for a different therapeutic indication, they may avoid infringement.
Q2: How does the scope of claims affect commercial potential?
A: Broader claims grant wider protection but are harder to obtain and sustain. Narrow claims restrict protection to specific embodiments.
Q3: Are there known patent challenges or oppositions to CN107001275?
A: No public records indicate oppositions or legal challenges; ongoing patent maintenance is critical.
Q4: How does this patent compare to international patents on similar compounds?
A: Similar patents in other jurisdictions, such as the US, often have comparable claims but may vary in scope due to legal frameworks.
Q5: What strategic considerations should companies consider regarding CN107001275?
A: Companies should analyze the patent’s claims in detail, assess the competitive landscape, and consider designing around the patent or licensing it for commercial activities.
References
[1] Chinese Patent Office. (2017). CN107001275. Retrieved from Chinese Patent Database.
[2] WIPO. (2022). Patent Landscape Reports.
[3] Chinese Patent Law. (2019). National People's Congress.
